RCS - Aberdeen Emerg IncCo - Update research from QuotedData

abrdn China InvestmentAnnouncement

15/08/2019 14:05

RNS Number : 2235J
Aberdeen Emerging Markets Inv Co Ld
15 August 2019
 


Aberdeen Emerging Markets - Update research from QuotedData
15th August 2019
The stars may be aligning
 
Year to date, Aberdeen Emerging Markets (AEMC) has been performing well, outstripping both its benchmark and the average of competing funds by some margin (see page 9). The members of the investment management team, who predicted a resurgence in AEMC's performance in 2019, believe there is more to come over the remainder of the year. They highlight that, globally, investors still have an underweight exposure to emerging markets. In addition, the recent interest rate cut in the US could signal a halt to US dollar strength, to the benefit of emerging market currencies and stock markets.
 
Full research: 
https://quoteddata.com/research/aberdeen-emerging-markets-stars-aligning-2/
 
This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.
NB: this note has been prepared for Aberdeen Emerging Markets by Marten & Co and is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.



QUOTEDDATA

123a Kings Road | London SW3 4PL

Tel: +44 (0) 20 3691 9430
www.quoteddata.com | research@quoteddata.com | www.martenandco.com 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUVRORKRAWAAR